Association of MCP-1, hsCRP, Neopterin, MMP-9 and NT-proBNP With Coronary Heart Disease Risk in Patients With Prior Stroke or Transient Ischemic Attack. Results of the Analysis of 13 Biomarkers From the SPARCL Trial

被引：0

作者：

Ganz, Peter ^{[1
]}

Amarenco, Pierre ^{[2
,3
]}

Goldstein, Larry B. ^{[4
]}

Sillesen, Henrik ^{[5
]}

Bao, Weihang ^{[6
]}

Preston, Gregory M. ^{[7
]}

Welch, K. M. ^{[8
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94143 USA

[2] Hop Xavier Bichat, Dept Neurol, Paris, France

[3] Hop Xavier Bichat, Stroke Cntr, Paris, France

[4] Duke Univ, Med Cntr, Duke Stroke Cntr, Durham, NC USA

[5] Univ Copenhagen, Rigshosp, Dept Vasc Surg, RK, DK-2100 Copenhagen, Denmark

[6] Pfizer Inc, Primary Care Stat, New York, NY USA

[7] Pfizer Inc, R&D, New York, NY USA

[8] Rosalind Franklin Univ Med & Sci, Off President, N Chicago, IL USA

来源：

关键词：

Coronary hear disease; Biomarkers; Stroke; Statins; Risk factors;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

14940

引用

页数：2

共 3 条